Navigation Links
ASA404 in Medical Technology

Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial

LONDON, 12 July 2007 - Cancer drug developer Antisoma plc (LSE: ASM, US OTC: ATSMY) today announces new data from its phase II trial of ASA404 in recurrent, platinum-sensitive ovarian cancer. This trial compares patients receiving ASA404 plus chemotherapy (n=37) with patients receiving chemotherap...

Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting

...squamous and non-squamous non-small cell lung cancer patients receiving asa404 (Abstract #8072: Sunday, June 1, 2008; 2:00 PM-6:00 PM CDT). Novartis...with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). asa404 is an investigational small-molecule Tumor-VDA that selectively disrupts ex...
ASA404 in Biological Technology

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...in Prostate Cancer II-53 Isis and OncoGenex Reveals Positive results of OGX-011 Molecule in HRPC II-53 Antisoma Completes Phase 2 Study of asa404 in Prostate Cancer II-53 Cougar Conducts Phase I/II Clinical Trials on CB7630 in Patients with Prostate Cancer II-54 Ambrilia Unveils Resu...
ASA404 in other areas

Vadimezan - Wikipedia, the free encyclopedia

Vadimezan or ASA404 is a tumor-vascular disrupting agent (tumor-VDA) that attacks the blood supply of a cancerous tumor to cause tumor regression.

Novartis Oncology Research: ASA404 For Lung Cancer

Read information about ASA404, a Novartis Oncology investigational cancer treatment that disrupts established tumor vasculature, inhibiting tumor blood flow and ...

ASA404 Vascular Disrupting Agent for Solid Tumours - Drug Development ...

Project on the ASA404 vascular disrupting agent for solid tumours by Antisoma and Novartis. ... Novartis subsequently acquired worldwide rights to ASA404 in 2007. ...

Positive data on Antisoma's ASA404 presented at ASCO | Reuters

LONDON, UK, Jun 01 (MARKET WIRE) -- London, UK, and Chicago, IL, 1 June 2008 - Antisoma (LSE: ASM; USOTC:ATSMY) announces that two presentations supporting ASA404 ...

starting a Phase III trial for the drug, ASA404

ASA404 ... Novel mechanism of action of ASA404 disrupts existing blood supply to tumors ... ASA404 is one of six novel oncology compounds Novartis is developing for ...

ATTRACT Clinical Trial – Antivascular Targeted Therapy: Researching ...

Learn about ATTRACT clinical trial from Novartis Oncology, and investigational cancer treatment: Antivascular Targeted Therapy: Researching ASA404 in Cancer Treatment.
Other Tags
(Date:4/28/2015)... Georgia State University’s School of Public Health has ... with the school on efforts to improve policies and ... more tobacco and has more smokers than any other ... Partnership-Tobacco Free Cities, will focus on a group of ... control efforts and where public health organizations are in ...
(Date:4/28/2015)... 2015 Tools4ever, the market leader ... today that they have been chosen by IT ... Identity and Access Management vendors. IT Central Station ... and Access Management tools by real users in ... analyzed their trends to come up with the ...
(Date:4/28/2015)... 2015 A new survey from National ... damage, 66 percent of Americans fear brain damage the most. ... Month in May, shed light on the need for greater ... prevent a stroke. By controlling modifiable risk factors, 80 ... is a “ brain attack ” that occurs when blood ...
(Date:4/28/2015)... April 28, 2015 A first-in-human ... of Molecular Imaging and Biology showed initial safety, ... generation fluorine-18 labeled small-molecule PSMA inhibitor. The imaging ... in Baltimore, MD by study co-author, Martin G. ... evaluation of [18F]DCFPyL demonstrated a number of important ...
(Date:4/28/2015)... 2015 Colorado spine surgeon Donald Corenman, ... his popular spine education website NECKANDBACK.COM and ... eMedical Media. This website has been redesigned to help ... the spine, causes of neck and back pain, and ... website and personally answers questions in the neck and ...
Breaking Medicine News(10 mins):Health News:Georgia State Names Partner Cities For Tobacco Control Project 2Health News:Tools4ever Chosen as Part of “Top Identity and Access Management Tools - 2015 Edition” 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 3Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 2Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 3
(Date:4/27/2015)... 2015  For more than four decades, AUVSI,s ... the premier worldwide event for the unmanned land, sea, ... event for any local, national, or trade news organization ... markets and current applications of unmanned technologies. The conference ... $48 billion industry, and how it will soon impact ...
(Date:4/27/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... first week of May, 2015 and will be fulfilling ... Gino Pereira , Chief Executive Officer ... as Wocket® enters the consumer market. We would like ...
(Date:4/27/2015)... , Apr. 27, 2015 Profile Solutions, Inc. ... and security systems is pleased to announce that Dr ... a consultant and member of its scientific advisory board. ... known as a thought leader in technology-enhanced learning models. ... Group, and has published studies and books focused on ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
Other Contents